Signaling pathways
-
BA5519 FesoterodineSummary: Fesoterodine is an orally effective, non-subtype-selective, competitive muscarinic receptor antagonist. - BA5520 ZamifenacinSummary: Zamifenacin (UK-76654) is a potent intestinal selective muscarinic receptor antagonist.
- BA5521 NuvenzepineSummary: Nuvenzepine is an antagonist.
- BA5522 AnagyrineSummary: Anagyrine ((-)-Anagyrine) is a quinoline alkaloid.
- BA5523 VU6000918Summary: VU6000918 is a muscarinic acetylcholine-positive variable modulator.
- BA5525 VU0152099Summary: VU0152099 is a potent, selective and orthosteric modulator that crosses the blood-brain barrier.
- BA5526 DexetimideSummary: Dexetimide ((+)-Benzetimide; (S)-(+)-Dexetimide; Dexbenzetimide) is a piperidine anticholinergic and a muscarinic receptor antagonist with high affinity.
- BA5527 LevetimideSummary: Levetimide is a potent stereoselective [H](+) pentazocine binding inhibitor.
- BA5528 PiperidolateSummary: Piperidolate is an anticholinergic agent.
- BA5529 YM-58790Summary: YM-58790 is a potent antagonist.